The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization.

The role of natural killer (NK) cells and NK cell receptor polymorphisms in the assessment of HIV-1 neutralization.

The importance of innate immune cells in HIV-1 pathogenesis and protection has been highlighted by the role of natural killer (NK) cells in the containment of viral replication. Use of peripheral blood mononuclear cells (PBMC) in immunologic studies provides both HIV-1 target cells (ie. CD4+ T cells...

Bibliografski detalji
Glavni autori:	Bruce K Brown, Lindsay Wieczorek, Gustavo Kijak, Kara Lombardi, Jeffrey Currier, Maggie Wesberry, John C Kappes, Viseth Ngauy, Mary Marovich, Nelson Michael, Christina Ochsenbauer, David C Montefiori, Victoria R Polonis
Format:	Članak
Jezik:	English
Izdano:	Public Library of Science (PLoS) 2012-01-01
Serija:	PLoS ONE
Online pristup:	http://europepmc.org/articles/PMC3324450?pdf=render

Slični predmeti

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
od: Montefiori D, i dr.
Izdano: (2009-10-01)

Natural killer T cells (NK T cells) functions in malignancies
od: Sima balouchi-anaraki, i dr.
Izdano: (2018-09-01)

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
od: Dorothy K Sojka, i dr.
Izdano: (2014-04-01)

P10-12. Altered NK cell phenotype and function in Ugandans with chronic HIV-1 infection
od: Robb ML, i dr.
Izdano: (2009-10-01)

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells
od: Mattias Carlsten, i dr.
Izdano: (2019-10-01)

Natural Killer (NK) cells in immunotherapy and perspectives in antitumour approaches
od: Lu Yihua
Izdano: (2022-01-01)

Natural Killer (NK)- and T-Cell Engaging Antibody-Derived Therapeutics
od: Christoph Stein, i dr.
Izdano: (2012-06-01)

Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.
od: Paolo Carrega, i dr.
Izdano: (2009-01-01)

TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells
od: Hwa-Youn Lee, i dr.
Izdano: (2021-05-01)

Enhancing a Natural Killer: Modification of NK Cells for Cancer Immunotherapy
od: Rasa Islam, i dr.
Izdano: (2021-04-01)

Non-Genetically Improving the Natural Cytotoxicity of Natural Killer (NK) Cells
od: Martin Villalba, i dr.
Izdano: (2020-01-01)

Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy
od: Lydia Navarrete-Galvan, i dr.
Izdano: (2022-04-01)

Natural killer cells for immunotherapy – Advantages of cell lines over blood NK cells
od: Hans eKlingemann, i dr.
Izdano: (2016-03-01)

Tumor-priming converts NK cells to memory-like NK cells
od: Marina Pal, i dr.
Izdano: (2017-06-01)

Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
od: Pingyi Liu, i dr.
Izdano: (2018-01-01)

Cordycepin Sensitizes Cholangiocarcinoma Cells to Be Killed by Natural Killer-92 (NK-92) Cells
od: Suthida Panwong, i dr.
Izdano: (2021-10-01)

Identification of human NK17/NK1 cells.
od: Abhilash D Pandya, i dr.
Izdano: (2011-01-01)

Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
od: Arum Park, i dr.
Izdano: (2018-08-01)

EVALUATION OF MICROVESICLES FORMED BY NATURAL KILLER (NK) CELLS USING FLOW CYTOMETRY
od: V. A. Mikhailova, i dr.
Izdano: (2018-03-01)

Naturally Killing the Silent Killer: NK Cell-Based Immunotherapy for Ovarian Cancer
od: Sarah Nersesian, i dr.
Izdano: (2019-08-01)

Atividade Antileucêmica das Células Natural Killer (NK)
od: Aline Almeida Oliveira, i dr.
Izdano: (2008-09-01)

991 Effects of SAR443579, a trifunctional anti-CD123 NK cell engager (NKCE), on natural killer (NK) cell subsets at the single cell level
od: Franck Auge, i dr.
Izdano: (2023-11-01)

Impact of HIV-1 backbone on neutralization sensitivity: neutralization profiles of heterologous envelope glycoproteins expressed in native subtype C and CRF01_AE backbone.
od: Agnès-Laurence Chenine, i dr.
Izdano: (2013-01-01)

Symptomatic Carotid Atherosclerotic Plaques Are Associated With Increased Infiltration of Natural Killer (NK) Cells and Higher Serum Levels of NK Activating Receptor Ligands
od: Irene Bonaccorsi, i dr.
Izdano: (2019-07-01)

NK-B cell cross talk induces CXCR5 expression on natural killer cells
od: Philippe Rascle, i dr.
Izdano: (2021-10-01)

NK cells and pre-eclampsia.
od: Sargent, I, i dr.
Izdano: (2007)

NK Cell Exhaustion
od: Jiacheng Bi, i dr.
Izdano: (2017-06-01)

NK cells in renal cell carcinoma and its implications for CAR-NK therapy
od: Xinwei Li, i dr.
Izdano: (2025-02-01)

MiRNAs and lncRNAs in NK cell biology and NK/T-cell lymphoma
od: FengXia Gao, i dr.
Izdano: (2021-09-01)

Indolent NK cell proliferative lesion mimicking NK/T cell lymphoma in the gallbladder
od: Su Hyun Hwang, i dr.
Izdano: (2016-09-01)

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization
od: Allison B. Powell, i dr.
Izdano: (2019-09-01)

The nature of the natural killer (NK) cell of human intestinal mucosa and mesenteric lymph node.
od: Gibson, P, i dr.
Izdano: (1985)

Selective modulation of Natural Killer (NK) cell phenotypes through chromatin modifying mechanisms
od: Cribbs, A, i dr.
Izdano: (2016)

Human natural killer (NK) cell activation by luteolin from Brucea javanica leaves
od: Ismail, Norzila, i dr.
Izdano: (2018)

A rare case of disseminated extra-nodal natural killer (NK) cell lymphoma
od: Sowbharnika Arivazhagan, i dr.
Izdano: (2024-09-01)

Natural Killer Cell Line NK-92-Mediated Damage of Medically Important Fungi
od: Stanislaw Schmidt, i dr.
Izdano: (2021-02-01)

PB1715: UNLEASHING NATURAL KILLER (NK) CELLS TO PROMOTE ANTI-LEUKEMIC IMMUNITY
od: Ioanna Tsoukala, i dr.
Izdano: (2023-08-01)

The Role of Natural Killer (NK) Cells in Acute Coronary Syndrome: A Comprehensive Review
od: Marko Kumrić, i dr.
Izdano: (2020-11-01)

Natural Killer (NK) cell responses at female genital mucosa to SIV vaginal challenge
od: Shang L, i dr.
Izdano: (2012-09-01)

Harnessing soluble NK cell killer receptors for the generation of novel cancer immune therapy.
od: Tal I Arnon, i dr.
Izdano: (2008-01-01)